Commonwealth Equity Services, LLC Immunity Bio, Inc. Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 20,575 shares of IBRX stock, worth $104,932. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,575
Previous 18,175
13.2%
Holding current value
$104,932
Previous $115,000
33.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IBRX
# of Institutions
204Shares Held
70MCall Options Held
1.68MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$86.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$58.3 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$44.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$19.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$11.5 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.04B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...